Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Current status and future directions of post-marketing vaccine safety monitoring with focus on USA and Europe.

Bonhoeffer J, Black S, Izurieta H, Zuber P, Sturkenboom M.

Biologicals. 2012 Sep;40(5):393-7. doi: 10.1016/j.biologicals.2012.07.007. Epub 2012 Aug 17. Review. Erratum in: Biologicals. 2013 Mar;41(2):128.

PMID:
22902972
2.

The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines.

Lopalco PL, DeStefano F.

Vaccine. 2015 Mar 24;33(13):1541-8. doi: 10.1016/j.vaccine.2014.10.047. Epub 2014 Nov 4. Review.

3.

Monitoring and assessing vaccine safety: a European perspective.

Lopalco PL, Johansen K, Ciancio B, De Carvalho Gomes H, Kramarz P, Giesecke J.

Expert Rev Vaccines. 2010 Apr;9(4):371-80. doi: 10.1586/erv.10.20. Review.

PMID:
20370548
4.

Post-licensure monitoring of HPV vaccine in the United States.

Markowitz LE, Hariri S, Unger ER, Saraiya M, Datta SD, Dunne EF.

Vaccine. 2010 Jul 5;28(30):4731-7. doi: 10.1016/j.vaccine.2010.02.019. Epub 2010 Feb 25. Review.

PMID:
20188681
5.

The Vaccine Safety Datalink: a model for monitoring immunization safety.

Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, Naleway A, Klein NP, Baxter R, Belongia E, Glanz J, Hambidge SJ, Jacobsen SJ, Jackson L, Nordin J, Weintraub E.

Pediatrics. 2011 May;127 Suppl 1:S45-53. doi: 10.1542/peds.2010-1722H. Epub 2011 Apr 18. Review.

PMID:
21502240
6.
7.

The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.

McNeil MM, Gee J, Weintraub ES, Belongia EA, Lee GM, Glanz JM, Nordin JD, Klein NP, Baxter R, Naleway AL, Jackson LA, Omer SB, Jacobsen SJ, DeStefano F.

Vaccine. 2014 Sep 22;32(42):5390-8. doi: 10.1016/j.vaccine.2014.07.073. Epub 2014 Aug 6. Review.

PMID:
25108215
8.

Enhancing vaccine safety capacity globally: A lifecycle perspective.

Chen RT, Shimabukuro TT, Martin DB, Zuber PL, Weibel DM, Sturkenboom M.

Vaccine. 2015 Nov 27;33 Suppl 4:D46-54. doi: 10.1016/j.vaccine.2015.06.073. Epub 2015 Oct 1. Review.

9.

Allergic reactions to Japanese encephalitis vaccine.

Plesner AM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. Review. Erratum in: Immunol Allergy Clin North Am. 2004 May;24(2):335.

PMID:
14753386
10.

Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?

Trifirò G, Coloma PM, Rijnbeek PR, Romio S, Mosseveld B, Weibel D, Bonhoeffer J, Schuemie M, van der Lei J, Sturkenboom M.

J Intern Med. 2014 Jun;275(6):551-61. doi: 10.1111/joim.12159. Review.

11.

Perspectives on the future of postmarket vaccine safety surveillance and evaluation.

Ball R.

Expert Rev Vaccines. 2014 Apr;13(4):455-62. Review.

PMID:
24606417
12.

Epidemiologic methods in immunization programs.

Chen RT, Orenstein WA.

Epidemiol Rev. 1996;18(2):99-117. Review.

PMID:
9021306
13.

Surveillance of adverse effects following vaccination and safety of immunization programs.

Waldman EA, Luhm KR, Monteiro SA, Freitas FR.

Rev Saude Publica. 2011 Feb;45(1):173-84. Review. English, Portuguese.

14.

Enhancing Vaccine Safety Capacity Globally: A Lifecycle Perspective.

Chen RT, Shimabukuro TT, Martin DB, Zuber PL, Weibel DM, Sturkenboom M.

Am J Prev Med. 2015 Dec;49(6 Suppl 4):S364-76. doi: 10.1016/j.amepre.2015.09.009. Review.

PMID:
26590436
15.

Statistical, epidemiological, and risk-assessment approaches to evaluating safety of vaccines throughout the life cycle at the Food and Drug Administration.

Ball R, Horne D, Izurieta H, Sutherland A, Walderhaug M, Hsu H.

Pediatrics. 2011 May;127 Suppl 1:S31-8. doi: 10.1542/peds.2010-1722F. Epub 2011 Apr 18. Review.

PMID:
21502249
16.

Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink.

Kharbanda EO, Vazquez-Benitez G, Shi WX, Lipkind H, Naleway A, Molitor B, Kuckler L, Olsen A, Nordin JD.

Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S47-51. doi: 10.1016/j.ajog.2012.06.073. Epub 2012 Jul 9. Review.

PMID:
22920059
17.

Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.

Global Advisory Committee on Vaccine Safety (GACVS); WHO secretariat.

Expert Rev Vaccines. 2009 Jun;8(6):705-16. doi: 10.1586/erv.09.40. Review.

PMID:
19485752
18.
19.

Vaccine effects and impact of vaccination programmes in post-licensure studies.

Hanquet G, Valenciano M, Simondon F, Moren A.

Vaccine. 2013 Nov 19;31(48):5634-42. doi: 10.1016/j.vaccine.2013.07.006. Epub 2013 Jul 13. Review.

PMID:
23856332
20.

Field evaluation of vaccine safety.

Tozzi AE.

Vaccine. 2004 May 7;22(15-16):2091-5. Review.

PMID:
15121330

Supplemental Content

Support Center